APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multiplex Immunofluorescence Assay

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Multiplex Immunofluorescence Assay Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchMultiplex Immunofluorescence Assay Industry Research Report 2026102 pages · $2,950 USDIndustry Growth & TrendsGlobal Multiplex Immunofluorescence Assay Industry Growth and Trends Forecast to 203264 pages · $3,450 USDMarket StructureGlobal Multiplex Immunofluorescence Assay Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multiplex Immunofluorescence Assay Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Multiplex Immunofluorescence Assay Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Multiplex Immunofluorescence Assay market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Multiplex Immunofluorescence Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Multiplex Immunofluorescence Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multiplex Immunofluorescence Assay is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Multiplex Immunofluorescence Assay market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Multiplex Immunofluorescence Assay market include Fluidigm and Akoya Biosciences among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Multiplex Immunofluorescence Assay market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Multiplex Immunofluorescence Assay and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Multiplex Immunofluorescence Assay revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Multiplex Immunofluorescence Assay market.

Multiplex Immunofluorescence Assay Segment by Company

Fluidigm

Akoya Biosciences

Multiplex Immunofluorescence Assay Segment by Type

Material

Equipment

Software and Service

Multiplex Immunofluorescence Assay Segment by Application

Academic and Research Institution

Hospital

Others

Multiplex Immunofluorescence Assay Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Multiplex Immunofluorescence Assay status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Multiplex Immunofluorescence Assay key companies, revenue, market share, and recent developments.

3. To split the Multiplex Immunofluorescence Assay breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Multiplex Immunofluorescence Assay market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Multiplex Immunofluorescence Assay significant trends, drivers, influence factors in global and regions.

6. To analyze Multiplex Immunofluorescence Assay competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Immunofluorescence Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multiplex Immunofluorescence Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Immunofluorescence Assay.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multiplex Immunofluorescence Assay industry.

Chapter 3: Detailed analysis of Multiplex Immunofluorescence Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Multiplex Immunofluorescence Assay in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Multiplex Immunofluorescence Assay in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Multiplex Immunofluorescence Assay Industry Trends Table 2. Multiplex Immunofluorescence Assay Industry Drivers Table 3. Multiplex Immunofluorescence Assay Industry Opportunities and Challenges Table 4. Multiplex Immunofluorescence Assay Industry Restraints Table 5. Global Multiplex Immunofluorescence Assay Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Multiplex Immunofluorescence Assay Revenue Share by Company (2021-2026) Table 7. Global Multiplex Immunofluorescence Assay Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Multiplex Immunofluorescence Assay Key Company Manufacturing Base & Headquarters Table 9. Global Multiplex Immunofluorescence Assay Company, Product Type & Application Table 10. Global Multiplex Immunofluorescence Assay Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Multiplex Immunofluorescence Assay by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Material Table 15. Significant Companies of Equipment Table 16. Significant Companies of Software and Service Table 17. Global Multiplex Immunofluorescence Assay Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Multiplex Immunofluorescence Assay Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Multiplex Immunofluorescence Assay Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Multiplex Immunofluorescence Assay Sales Value Share by Type (2021-2026) Table 21. Global Multiplex Immunofluorescence Assay Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Academic and Research Institution Table 23. Significant Companies of Hospital Table 24. Significant Companies of Others Table 25. Global Multiplex Immunofluorescence Assay Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Multiplex Immunofluorescence Assay Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Multiplex Immunofluorescence Assay Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Multiplex Immunofluorescence Assay Sales Value Share by Application (2021-2026) Table 29. Global Multiplex Immunofluorescence Assay Sales Value Share by Application (2027-2032) Table 30. Global Multiplex Immunofluorescence Assay Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Multiplex Immunofluorescence Assay Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Multiplex Immunofluorescence Assay Sales Value Share by Region (2021-2026) Table 33. Global Multiplex Immunofluorescence Assay Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Multiplex Immunofluorescence Assay Sales Value Share by Region (2027-2032) Table 35. Global Multiplex Immunofluorescence Assay Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Multiplex Immunofluorescence Assay Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Multiplex Immunofluorescence Assay Sales Value Market Share by Country (2021-2026) Table 38. Global Multiplex Immunofluorescence Assay Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Multiplex Immunofluorescence Assay Sales Value Market Share by Country (2027-2032) Table 40. Fluidigm Company Information Table 41. Fluidigm Business Overview Table 42. Fluidigm Multiplex Immunofluorescence Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Fluidigm Multiplex Immunofluorescence Assay Product Portfolio Table 44. Fluidigm Recent Development Table 45. Akoya Biosciences Company Information Table 46. Akoya Biosciences Business Overview Table 47. Akoya Biosciences Multiplex Immunofluorescence Assay Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Akoya Biosciences Multiplex Immunofluorescence Assay Product Portfolio Table 49. Akoya Biosciences Recent Development Table 50. Research Programs/Design for This Report Table 51. Authors List of This Report Table 52. Secondary Sources Table 53. Primary Sources List of Figures Figure 1. Multiplex Immunofluorescence Assay Product Image Figure 2. Global Multiplex Immunofluorescence Assay Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multiplex Immunofluorescence Assay Market Size (2021-2032) & (US$ Million) Figure 4. Global Multiplex Immunofluorescence Assay Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Material Image Figure 8. Equipment Image Figure 9. Software and Service Image Figure 10. Global Multiplex Immunofluorescence Assay Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Multiplex Immunofluorescence Assay Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Multiplex Immunofluorescence Assay Sales Value Share by Type (2021-2032) Figure 13. Academic and Research Institution Image Figure 14. Hospital Image Figure 15. Others Image Figure 16. Global Multiplex Immunofluorescence Assay Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Multiplex Immunofluorescence Assay Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Multiplex Immunofluorescence Assay Sales Value Share by Application (2021-2032) Figure 19. Global Multiplex Immunofluorescence Assay Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Multiplex Immunofluorescence Assay Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Multiplex Immunofluorescence Assay Sales Value (2021-2032) & (US$ Million) Figure 22. North America Multiplex Immunofluorescence Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Multiplex Immunofluorescence Assay Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Multiplex Immunofluorescence Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Multiplex Immunofluorescence Assay Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Multiplex Immunofluorescence Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Multiplex Immunofluorescence Assay Sales Value (2021-2032) & (US$ Million) Figure 28. South America Multiplex Immunofluorescence Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Multiplex Immunofluorescence Assay Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Multiplex Immunofluorescence Assay Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Material
  • Equipment
  • Software and Service
Applications
  • Academic and Research Institution
  • Hospital
  • Others
Companies covered
  • Fluidigm
  • Akoya Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Multiplex Immunofluorescence Assay Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Multiplex Immunofluorescence Assay Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Multiplex Immunofluorescence Assay Market Dynamics
  1. 2.1 Multiplex Immunofluorescence Assay Industry Trends
  2. 2.2 Multiplex Immunofluorescence Assay Industry Drivers
  3. 2.3 Multiplex Immunofluorescence Assay Industry Opportunities and Challenges
  4. 2.4 Multiplex Immunofluorescence Assay Industry Restraints
3 Multiplex Immunofluorescence Assay Market by Company
  1. 3.1 Global Multiplex Immunofluorescence Assay Company Revenue Ranking in 2025
  2. 3.2 Global Multiplex Immunofluorescence Assay Revenue by Company (2021-2026)
  3. 3.3 Global Multiplex Immunofluorescence Assay Company Ranking (2024-2026)
  4. 3.4 Global Multiplex Immunofluorescence Assay Company Manufacturing Base and Headquarters
  5. 3.5 Global Multiplex Immunofluorescence Assay Company Product Type and Application
  6. 3.6 Global Multiplex Immunofluorescence Assay Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Multiplex Immunofluorescence Assay Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Multiplex Immunofluorescence Assay Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Multiplex Immunofluorescence Assay Market by Type
  1. 4.1 Multiplex Immunofluorescence Assay Type Introduction
  2. 4.1.1 Material
  3. 4.1.2 Equipment
  4. 4.1.3 Software and Service
  5. 4.2 Global Multiplex Immunofluorescence Assay Sales Value by Type
  6. 4.2.1 Global Multiplex Immunofluorescence Assay Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Multiplex Immunofluorescence Assay Sales Value by Type (2021-2032)
  8. 4.2.3 Global Multiplex Immunofluorescence Assay Sales Value Share by Type (2021-2032)
5 Multiplex Immunofluorescence Assay Market by Application
  1. 5.1 Multiplex Immunofluorescence Assay Application Introduction
  2. 5.1.1 Academic and Research Institution
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Multiplex Immunofluorescence Assay Sales Value by Application
  6. 5.2.1 Global Multiplex Immunofluorescence Assay Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Multiplex Immunofluorescence Assay Sales Value by Application (2021-2032)
  8. 5.2.3 Global Multiplex Immunofluorescence Assay Sales Value Share by Application (2021-2032)
6 Multiplex Immunofluorescence Assay Regional Value Analysis
  1. 6.1 Global Multiplex Immunofluorescence Assay Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Multiplex Immunofluorescence Assay Sales Value by Region (2021-2032)
  3. 6.2.1 Global Multiplex Immunofluorescence Assay Sales Value by Region: 2021-2026
  4. 6.2.2 Global Multiplex Immunofluorescence Assay Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Multiplex Immunofluorescence Assay Sales Value (2021-2032)
  7. 6.3.2 North America Multiplex Immunofluorescence Assay Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Multiplex Immunofluorescence Assay Sales Value (2021-2032)
  10. 6.4.2 Europe Multiplex Immunofluorescence Assay Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Multiplex Immunofluorescence Assay Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Multiplex Immunofluorescence Assay Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Multiplex Immunofluorescence Assay Sales Value (2021-2032)
  16. 6.6.2 South America Multiplex Immunofluorescence Assay Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Multiplex Immunofluorescence Assay Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Multiplex Immunofluorescence Assay Sales Value Share by Country, 2025 VS 2032
7 Multiplex Immunofluorescence Assay Country-level Value Analysis
  1. 7.1 Global Multiplex Immunofluorescence Assay Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Multiplex Immunofluorescence Assay Sales Value by Country (2021-2032)
  3. 7.2.1 Global Multiplex Immunofluorescence Assay Sales Value by Country (2021-2026)
  4. 7.2.2 Global Multiplex Immunofluorescence Assay Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Multiplex Immunofluorescence Assay Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Multiplex Immunofluorescence Assay Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Multiplex Immunofluorescence Assay Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Fluidigm
  2. 8.1.1 Fluidigm Company Information
  3. 8.1.2 Fluidigm Business Overview
  4. 8.1.3 Fluidigm Multiplex Immunofluorescence Assay Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Fluidigm Multiplex Immunofluorescence Assay Product Portfolio
  6. 8.1.5 Fluidigm Recent Developments
  7. 8.2 Akoya Biosciences
  8. 8.2.1 Akoya Biosciences Company Information
  9. 8.2.2 Akoya Biosciences Business Overview
  10. 8.2.3 Akoya Biosciences Multiplex Immunofluorescence Assay Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Akoya Biosciences Multiplex Immunofluorescence Assay Product Portfolio
  12. 8.2.5 Akoya Biosciences Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst